We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$106B
AUM Growth
-$22.4B
Cap. Flow
+$44.2B
Cap. Flow %
41.6%
Top 10 Hldgs %
42.41%
Holding
4,108
New
765
Increased
1,315
Reduced
1,298
Closed
285

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.85B
2
EQIX icon
Equinix
EQIX
+$2.31B
3
TSLA icon
Tesla
TSLA
+$2.3B
4
SNDK
SANDISK CORP
SNDK
+$1.87B
5
TRLA
TRULIA INC (DEL)
TRLA
+$1.64B

Sector Composition

Rank Sector Weight
1 Technology 4.77%
2 Financials 3.07%
3 Industrials 1.75%
4 Healthcare 1.67%
5 Materials 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZN
3576
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$346 ﹤0.01%
+333
New +$317
EVOL
3577
DELISTED
Evolving Systems, Inc.
EVOL
$342 ﹤0.01%
40
CYTK icon
3578
Cytokinetics
CYTK
$10.8B
$339 ﹤0.01%
71
+52
+274% +$317
ECTE
3579
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$332 ﹤0.01%
147
CERE
3580
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$331 ﹤0.01%
62
CTRN icon
3581
Citi Trends
CTRN
$630M
$322 ﹤0.01%
+15
New +$280
LTRE
3582
DELISTED
LEARNING TREE INTL INC
LTRE
$320 ﹤0.01%
125
REFR icon
3583
Research Frontiers
REFR
$17M
$315 ﹤0.01%
52
TITN icon
3584
Titan Machinery
TITN
$445M
$313 ﹤0.01%
+19
New +$319
IEC
3585
DELISTED
IEC Electronics Corp.
IEC
$313 ﹤0.01%
72
PRTS icon
3586
CarParts.com
PRTS
$51.1M
$310 ﹤0.01%
9
JBTM
3587
JBT Marel
JBTM
$6.36B
$310 ﹤0.01%
+10
New +$297
NETE
3588
DELISTED
NETEGRITY INC
NETE
$309 ﹤0.01%
162
+67
+71% +$128
DEL
3589
DELISTED
Deltic Timber
DEL
$302 ﹤0.01%
+5
New +$306
COVS
3590
DELISTED
Covisint Corporation
COVS
$301 ﹤0.01%
+62
New +$388
STRL icon
3591
Sterling Infrastructure
STRL
$16.3B
$300 ﹤0.01%
32
-227
-88% -$1.93K
CPIX icon
3592
Cumberland Pharmaceuticals
CPIX
$116M
$297 ﹤0.01%
66
EGAS
3593
DELISTED
Gas Natural Inc.
EGAS
$295 ﹤0.01%
28
HDSN
3594
Hudson Technologies
HDSN
$237M
$289 ﹤0.01%
100
JMP
3595
DELISTED
JMP Group LLC
JMP
$288 ﹤0.01%
+38
New +$255
UAMY icon
3596
United States Antimony
UAMY
$963M
$287 ﹤0.01%
202
JRCC
3597
DELISTED
JAMES RIVER COAL NEW
JRCC
$282 ﹤0.01%
724
-12,383,000
-100% -$5.86M
BFIN
3598
DELISTED
BankFinancial
BFIN
$279 ﹤0.01%
25
+2
+9% +$20
CLRO icon
3599
ClearOne Inc
CLRO
$15.8M
$275 ﹤0.01%
2
KELYA icon
3600
Kelly Services Class A
KELYA
$533M
$275 ﹤0.01%
+16
New +$315

Similar funds

BNP Paribas Financial Markets's Q2 2014 Portfolio in Review

As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.

  • BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
  • BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
  • BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
  • BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
  • BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
  • BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
  • BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.